Come up with a name for your new list and we'll add to it:
Therapeutic Human Polyclonals raised a round of funding on , . Investors include
Research Corporation Technologies.
Therapeutic Human Polyclonals (THP) is an emerging biotechnology company focused on research in the field of human antibody technologies. THP has developed a unique transgenic mammalian platform to cr…